Science Explorer Back to mapMap
Discussion
Institution · Seongnam-si · South Korea

Korea Drug Development Fund

eng.kddf.org/MainROR OpenAlex
Research works
1
▼ 34% vs 2018-21
Citations
11
8.3 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
Open access
24%
world 40%
Korea Drug Development Fund

Not ranked overall: Korea Drug Development Fund is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Korea Drug Development Fund work in?

In all years, 62% of research at Korea Drug Development Fund is in Physical Sciences, 31% in Health Sciences. Its largest fields are Engineering (54%), Medicine (31%), Biochemistry, Genetics and Molecular Biology (8%).

Physical Sciences: 1 fractional works · 61.5% of its workEngineering: 1 fractional works · 53.8% of its workPhysics and Astronomy: 0 fractional works · 7.7% of its workHealth Sciences: 0 fractional works · 30.8% of its workMedicine: 0 fractional works · 30.8% of its workLife Sciences: 0 fractional works · 7.7% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 7.7% of its workALL ITS WORKKorea DrugDevelopment Fund1fractional works, all years
Life Sciences8%Physical Sciences62%Health Sciences31%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Engineering153.8%
    2. Physics and Astronomy07.7%
    1. Medicine030.8%
    1. Biochemistry, Genetics and Molecular Biology07.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Korea Drug Development Fund?

The most cited paper from Korea Drug Development Fund is "Synthesis and biological evaluation of novel thieno[2,3-d]pyrimidine-based FLT3 inhibitors as anti-leukemic agents" (Jee Sun Yang, Chun-Ho Park, Chulho Lee et al., 2014), with 25 citations. Next come "Structural modifications at the 6-position of thieno[2,3-d]pyrimidines and their effects on potency at FLT3 for treatment of acute myeloid leukemia" (15) and "A power efficient impulse generator for 6‐9 GHz UWB applications" (3).

Most cited papers
#PaperReleasedCitations
1 Synthesis and biological evaluation of novel thieno[2,3-d]pyrimidine-based FLT3 inhibitors as anti-leukemic agents Jee Sun Yang, Chun-Ho Park, Chulho Lee et al. · European Journal of Medicinal Chemistry Open access Aug 2014 25
2 Structural modifications at the 6-position of thieno[2,3-d]pyrimidines and their effects on potency at FLT3 for treatment of acute myeloid leukemia Hyuntae Kim, Chulho Lee, Jee Sun Yang et al. · European Journal of Medicinal Chemistry Open access 9 May 2016 15
3 A power efficient impulse generator for 6‐9 GHz UWB applications Won Il Jang, Woon Sung Choi, Tong Ook Kong et al. · Microwave and Optical Technology Letters 4 Dec 2018 3
All 3 most cited papers, with filters and sorting

Which research topics does Korea Drug Development Fund publish most on?

By volume in 2022-now: Microwave Engineering and Waveguides, Radio Frequency Integrated Circuit Design and Superconducting and THz Device Technology.

Microwave Engineering an…0Microwave Engineering and Waveguides: 0 fractional worksRadio Frequency Integrat…0Radio Frequency Integrated Circuit Design: 0 fractional worksSuperconducting and THz …0Superconducting and THz Device Technology: 0 fractional works
Electrical and Electronic EngineeringAstronomy and Astrophysics

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Microwave Engineering and Waveguides Electrical and Electronic Engineering 0 works
  2. 2 Radio Frequency Integrated Circuit Design Electrical and Electronic Engineering 0 works
  3. 3 Superconducting and THz Device Technology Astronomy and Astrophysics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.9%not open76.1%

World: 40% of research is openly available.

How has Korea Drug Development Fund's research output changed?

Output in 2022-2025 was 34% lower than in 2018-2021.

still counting201520202025

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Korea Drug Development Fund. Posts are plain text and can be reported.